Report Detail
Global Ranibizumab Market 2019 by Company, Regions, Type and Application, Forecast to 2024
- RnM3748146 |
- 14 September, 2019 |
- Global |
- 103 Pages |
- GIR (Global Info Research) |
- Pharma & Healthcare
Ranibizumab (trade name Lucentis among others) is a monoclonal antibody fragment (Fab) created from the same parent mouse antibody as bevacizumab. It is an anti-angiogenic that has been approved to treat the "wet" type of age-related macular degeneration (AMD, also ARMD), a common form of age-related vision loss.
Scope of the Report:
The global Ranibizumab market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Ranibizumab.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Ranibizumab market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Ranibizumab market by product type and applications/end industries.
Market Segment by Companies, this report covers
Genentech
Novartis
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Single-use prefilled syringe
Single-use glass vial
Market Segment by Applications, can be divided into
wAMD
Diabetic Retinopathy (DR)
Diabetic Macular Edema (DME)
mCNV
RVO
Table of Contents
1 Ranibizumab Market Overview
- 1.1 Product Overview and Scope of Ranibizumab
- 1.2 Classification of Ranibizumab by Types
- 1.2.1 Global Ranibizumab Revenue Comparison by Types (2019-2024)
- 1.2.2 Global Ranibizumab Revenue Market Share by Types in 2018
- 1.2.3 Single-use prefilled syringe
- 1.2.4 Single-use glass vial
- 1.3 Global Ranibizumab Market by Application
- 1.3.1 Global Ranibizumab Market Size and Market Share Comparison by Applications (2014-2024)
- 1.3.2 wAMD
- 1.3.3 Diabetic Retinopathy (DR)
- 1.3.4 Diabetic Macular Edema (DME)
- 1.3.5 mCNV
- 1.3.6 RVO
- 1.4 Global Ranibizumab Market by Regions
- 1.4.1 Global Ranibizumab Market Size (Million USD) Comparison by Regions (2014-2024)
- 1.4.1 North America (USA, Canada and Mexico) Ranibizumab Status and Prospect (2014-2024)
- 1.4.2 Europe (Germany, France, UK, Russia and Italy) Ranibizumab Status and Prospect (2014-2024)
- 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Ranibizumab Status and Prospect (2014-2024)
- 1.4.4 South America (Brazil, Argentina, Colombia) Ranibizumab Status and Prospect (2014-2024)
- 1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Ranibizumab Status and Prospect (2014-2024)
- 1.5 Global Market Size of Ranibizumab (2014-2024)
2 Manufacturers Profiles
- 2.1 Genentech
- 2.1.1 Business Overview
- 2.1.2 Ranibizumab Type and Applications
- 2.1.2.1 Product A
- 2.1.2.2 Product B
- 2.1.3 Genentech Ranibizumab Revenue, Gross Margin and Market Share (2017-2018)
- 2.2 Novartis
- 2.2.1 Business Overview
- 2.2.2 Ranibizumab Type and Applications
- 2.2.2.1 Product A
- 2.2.2.2 Product B
- 2.2.3 Novartis Ranibizumab Revenue, Gross Margin and Market Share (2017-2018)
3 Global Ranibizumab Market Competition, by Players
- 3.1 Global Ranibizumab Revenue and Share by Players (2014-2019)
- 3.2 Market Concentration Rate
- 3.2.1 Top 5 Ranibizumab Players Market Share
- 3.2.2 Top 10 Ranibizumab Players Market Share
- 3.3 Market Competition Trend
4 Global Ranibizumab Market Size by Regions
- 4.1 Global Ranibizumab Revenue and Market Share by Regions
- 4.2 North America Ranibizumab Revenue and Growth Rate (2014-2019)
- 4.3 Europe Ranibizumab Revenue and Growth Rate (2014-2019)
- 4.4 Asia-Pacific Ranibizumab Revenue and Growth Rate (2014-2019)
- 4.5 South America Ranibizumab Revenue and Growth Rate (2014-2019)
- 4.6 Middle East and Africa Ranibizumab Revenue and Growth Rate (2014-2019)
5 North America Ranibizumab Revenue by Countries
- 5.1 North America Ranibizumab Revenue by Countries (2014-2019)
- 5.2 USA Ranibizumab Revenue and Growth Rate (2014-2019)
- 5.3 Canada Ranibizumab Revenue and Growth Rate (2014-2019)
- 5.4 Mexico Ranibizumab Revenue and Growth Rate (2014-2019)
6 Europe Ranibizumab Revenue by Countries
- 6.1 Europe Ranibizumab Revenue by Countries (2014-2019)
- 6.2 Germany Ranibizumab Revenue and Growth Rate (2014-2019)
- 6.3 UK Ranibizumab Revenue and Growth Rate (2014-2019)
- 6.4 France Ranibizumab Revenue and Growth Rate (2014-2019)
- 6.5 Russia Ranibizumab Revenue and Growth Rate (2014-2019)
- 6.6 Italy Ranibizumab Revenue and Growth Rate (2014-2019)
7 Asia-Pacific Ranibizumab Revenue by Countries
- 7.1 Asia-Pacific Ranibizumab Revenue by Countries (2014-2019)
- 7.2 China Ranibizumab Revenue and Growth Rate (2014-2019)
- 7.3 Japan Ranibizumab Revenue and Growth Rate (2014-2019)
- 7.4 Korea Ranibizumab Revenue and Growth Rate (2014-2019)
- 7.5 India Ranibizumab Revenue and Growth Rate (2014-2019)
- 7.6 Southeast Asia Ranibizumab Revenue and Growth Rate (2014-2019)
8 South America Ranibizumab Revenue by Countries
- 8.1 South America Ranibizumab Revenue by Countries (2014-2019)
- 8.2 Brazil Ranibizumab Revenue and Growth Rate (2014-2019)
- 8.3 Argentina Ranibizumab Revenue and Growth Rate (2014-2019)
- 8.4 Colombia Ranibizumab Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue Ranibizumab by Countries
- 9.1 Middle East and Africa Ranibizumab Revenue by Countries (2014-2019)
- 9.2 Saudi Arabia Ranibizumab Revenue and Growth Rate (2014-2019)
- 9.3 UAE Ranibizumab Revenue and Growth Rate (2014-2019)
- 9.4 Egypt Ranibizumab Revenue and Growth Rate (2014-2019)
- 9.5 Nigeria Ranibizumab Revenue and Growth Rate (2014-2019)
- 9.6 South Africa Ranibizumab Revenue and Growth Rate (2014-2019)
10 Global Ranibizumab Market Segment by Type
- 10.1 Global Ranibizumab Revenue and Market Share by Type (2014-2019)
- 10.2 Global Ranibizumab Market Forecast by Type (2019-2024)
- 10.3 Single-use prefilled syringe Revenue Growth Rate (2014-2024)
- 10.4 Single-use glass vial Revenue Growth Rate (2014-2024)
11 Global Ranibizumab Market Segment by Application
- 11.1 Global Ranibizumab Revenue Market Share by Application (2014-2019)
- 11.2 Ranibizumab Market Forecast by Application (2019-2024)
- 11.3 wAMD Revenue Growth (2014-2019)
- 11.4 Diabetic Retinopathy (DR) Revenue Growth (2014-2019)
- 11.5 Diabetic Macular Edema (DME) Revenue Growth (2014-2019)
- 11.6 mCNV Revenue Growth (2014-2019)
- 11.7 RVO Revenue Growth (2014-2019)
12 Global Ranibizumab Market Size Forecast (2019-2024)
- 12.1 Global Ranibizumab Market Size Forecast (2019-2024)
- 12.2 Global Ranibizumab Market Forecast by Regions (2019-2024)
- 12.3 North America Ranibizumab Revenue Market Forecast (2019-2024)
- 12.4 Europe Ranibizumab Revenue Market Forecast (2019-2024)
- 12.5 Asia-Pacific Ranibizumab Revenue Market Forecast (2019-2024)
- 12.6 South America Ranibizumab Revenue Market Forecast (2019-2024)
- 12.7 Middle East and Africa Ranibizumab Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
- 14.1 Methodology
Summary:
Get latest Market Research Reports on Ranibizumab. Industry analysis & Market Report on Ranibizumab is a syndicated market report, published as Global Ranibizumab Market 2019 by Company, Regions, Type and Application, Forecast to 2024. It is complete Research Study and Industry Analysis of Ranibizumab market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
